StockNews.com Begins Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)

StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Down 5.9 % Shares of NASDAQ:TTNP opened at $0.26 on Friday. Titan Pharmaceuticals has a one year low […]

Related Keywords

Canada ,United States , ,Virtu Financial ,European Union ,Titan Pharmaceuticals Company Profile ,News Ratings For Titan Pharmaceuticals Daily ,Titan Pharmaceuticals Trading Down ,Nasdaq ,Millennium Management ,Hedge Funds Weigh In On Titan Pharmaceuticals ,Renaissance Technologies ,Titan Pharmaceuticals ,Titan Pharmaceuticals Inc ,Free Report ,Pharmaceuticals Trading Down ,Get Free Report ,Street Corp ,Titan Pharmaceuticals Daily ,Nasdaq Ttnp ,Ttnp ,Medical ,Initiated Coverage ,Stocknews Com ,